SOURCE: THC BioMed Intl Ltd.

THC Biomed Intl Ltd.

September 26, 2016 08:00 ET

THC Signs LOI to Purchase Clone Shipper for 1 Million USD

VANCOUVER, BC--(Marketwired - September 26, 2016) - THC BioMed Intl Ltd. ("THC" or the "Company")(CSE: THC)(OTC PINK: THCBF)(FRANKFURT: TFHC) is pleased to announce that it has signed an LOI to purchase 100% of Clone Shipper, a US based company, specializing in packaging products used to transport live plants, for 1 Million USD.

"I am pleased to have the opportunity to make this strategic purchase. Purchasing Clone Shipper allows THC to penetrate the US and the International Cannabis market, while remaining in line with the US and International laws, by not dealing directly with cannabis in countries where cannabis remains Federally illegal."

"The Global demand for Securely shipping Live plants is increasing with the legalization of Medical Cannabis. This is the early formation of our Global footprint we intend to place in the International Cannabis Market Place." announced John Miller, THC BioMed Intl CEO and President.

Clone shipper is currently the only device that meets Canadian and Federal International laws governing the transportation of controlled live plants.

THC intends to strengthen the patents protecting this Device and will ensure that this invention is protected under international laws.

Clone Shipper products are currently available for sale at gardening supply outlets throughout the USA. Clone shipper is also available on popular sites like Amazon.com International online sales and more information on the company can be found at www.cloneshipper.com

Management will continue to employ fiscal discipline as we asses and strategically move forward in building an international vertically integrated Cannabis conglomerate. Management continues to work diligently to increase shareholder value and meet the milestones it has set out to shareholders.

THC's vision is to be on the leading edge of scientific research, development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.

Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC. Forward-looking information is based on certain key expectations and assumptions made by the management of THC. Although THC believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Contact Information